Nevertheless, PGG treatment in DIO mice clearly improves a variety of obesity-related parameters, including dissected appearance, colon length, serum lipids, adipocyte size and lipid content, hepatic triglyceride accumulation and inflammation, insulin sensitivity, glucose tolerance, islet hypertrophy and insulin content and endocrine profile. The gene discussed is INS; the disease is obesity disorder.